[1]
2024. The impact of Empagliflozin on chronic kidney disease patient regardless of diabetes: A review. Asian Journal of Pharmaceutical and Health Sciences. 14, 4 (Dec. 2024), 3036–3040. DOI:https://doi.org/10.5530/qzdgq624.